Work

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer

Year: 2007

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/sj.cgt.7701069

Authors: H Wang, G Yang, T L Timme, T Fujita, K Naruishi, A Frolov, M K Brenner, D Kadmon, T C Thompson

Institution: Baylor College of Medicine

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Public Health Service, National Cancer Institute

Award: G1589627612

OpenAlex ID: W2006376071

FWCI: 0.548

Cites: 41

Cited by: 14

Related to: 10